Alan is a member of the CBRE Boston Consulting practice with expertise in life science operations and lab strategy. He has over 20 years of experience in the biotechnology and pharmaceutical industries where he has served in both scientific and operational capacities.
Prior to joining CBRE, Alan was the Head of Global Operations for Johnson & Johnson Innovation, JLABS. There he led the overall strategy for the first to market and leading life sciences incubator, setting new benchmark standards for the industry. At JLABS, he was responsible for setting the strategic direction, planning and execution of the business worldwide, growing the portfolio of companies to over 500 across 13 locations. Previously, he held scientific positions at the Salk Institute, Novartis and Ambrx where he focused on gene expression and new drug development to treat inflammatory, cardiovascular and metabolic diseases.
- University of California, San Diego (UCSD), B.S. in Biochemistry and Cell Biology
- University of San Diego, MBA with emphases in Real Estate, Finance and Leadership